- Telehealth Visits
- Insurance plan information
Yerem Yeghiazarians, MD
Valvular Disease Cardiology • Interventional Cardiology- Telehealth Visits
- Insurance plan information
Yerem Yeghiazarians, MD
Valvular Disease Cardiology • Interventional Cardiology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Yerem Yeghiazarians is an interventional cardiologist and an expert in managing patients with coronary artery disease, acute coronary syndromes, valvular heart disease, cardiomyopathies, and peripheral arterial diseases.
Yeghiazarians earned an undergraduate degree from Brandeis University and a medical degree from the Johns Hopkins School of Medicine. He trained in internal medicine at Brigham and Women's Hospital, a teaching affiliate of Harvard Medical School, where he was chief medical resident and an instructor in medicine. He also completed training in general and interventional adult cardiology at Brigham and Women's Hospital.
Education & training
Board certification
- Interventional Cardiology, American Board of Internal Medicine
Fellowship
- Advanced Interventional Cardiology, Brigham and Womens Hospital GME
- Interventional Cardiology, Brigham and Womens Hospital GME
- Cardiovascular Disease, Brigham and Womens Hospital GME
Residency
- Internal Medicine, Brigham & Women's Hospital
- Internal Medicine, Brigham and Womens Hospital GME
Internship
- Internal Medicine, Brigham and Womens Hospital GME
Degree
- MD, Johns Hopkins University School of Medicine
My expertise
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%22954%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%22954%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.